(Q43584802)

English

Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition

scientific article published on 16 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

Renée Turzanski Fortner

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Giovanna Masala

18

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Carlotta Sacerdote

21

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Amalia Mattiello

22

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Elisabete Weiderpass

35

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bas Bueno-de-Mesquita

30

object named as

H Bas Bueno-de-Mesquita

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

13

object named as

Heiner Boeing

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Aurelio Barricarte

28

object named as

Aurelio Barricarte

0 references

María-Dolores Chirlaque

26

object named as

María-Dolores Chirlaque

0 references

Nerea Larrañaga

25

object named as

Nerea Larrañaga

0 references

Mireia Obón-Santacana

object named as

Mireia Obón-Santacana

24

0 references

Anne Tjønneland

object named as

Anne Tjonneland

6

0 references

object named as

Domenico Palli

17

0 references

43

object named as

Rudolf Kaaks

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

20

object named as

Rosario Tumino

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

5

object named as

Kim Overvad

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Antonia Trichopoulou

14

object named as

Antonia Trichopoulou

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimitris Trichopoulos

16

object named as

Dimitrios Trichopoulos

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

15

object named as

Pagona Lagiou

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

37

object named as

Eiliv Lund

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Laura Baglietto

10

object named as

Laura Baglietto

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

33

object named as

Eva Lundin

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

object named as

Sabina Rinaldi

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

39

object named as

Ruth C Travis

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Isabelle Romieu

11

object named as

Isabelle Romieu

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

N Charlotte Onland-Moret

31

object named as

N Charlotte Onland-Moret

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Jennifer Ose

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Helena Schock

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Louise Hansen

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Laure Dossus

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Agnes Fournier

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Elisabetta Kuhn

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Jose Ramon Quiros

23

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

María-Dolores Chirlaque

26

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

María-José Sánchez

27

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Petra H Peeters

29

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Jenny Brändstedt

32

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Annika Idahl

34

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Inger T Gram

36

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kay-Tee Kaw

38

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Melissa A Merritt

40

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Marc J Gunther

41

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

16 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

399-410

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Hormonal control of programmed cell death/apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Hormone response in ovarian cancer: time to reconsider as a clinical target?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Ovarian Cancer Is an Imported Disease: Fact or Fiction?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Differences in tumor type in low-stage versus high-stage ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Plasma androgen concentrations and risk of incident ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Circulating levels of sex steroid hormones and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Use of urine biomarkers to evaluate menstrual function in healthy premenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Clear cell cancer of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Clinicopathologic and immunohistochemical features of ovarian clear cell carcinomas in comparison with type I and type II tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Simulation study of confounder-selection strategies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

DHEA metabolites activate estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Premenopausal serum androgens and breast cancer risk: a nested case-control study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Endogenous Androgens and Risk of Epithelial Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29000

21 January 2018

Identifiers

10.1002/IJC.29000

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43584802&oldid=2101680145"